Abamune L Tablet – Abacavir 600mg + Lamivudine 300mg HIV Combination Therapy
Abamune L (Abacavir / Lamivudine) is a prescription antiretroviral medication used in the treatment of HIV infection. As part of a combination antiretroviral therapy (cART) regimen, it suppresses HIV viral load to undetectable levels, protecting the immune system and significantly improving quality of life.
Composition: Abacavir (600mg) + Lamivudine (300mg)
Key Benefits:
- Reduces HIV viral load to undetectable levels
- Preserves and rebuilds CD4+ T-cell count (immune function)
- Dramatically lowers the risk of opportunistic infections
- Prevents progression to AIDS when taken consistently
Manufacturer: Cipla Ltd
Prescription-only antiretroviral. Must be taken as part of a complete HIV regimen under the guidance of an infectious disease specialist.
Composition Abacavir (600mg) + Lamivudine (300mg)
Dosage Form Tablets
Equivalent brand Epzicom
Generic Name Abacavir / Lamivudine
Indication HIV infection
Manufacturer Cipla Ltd
Packaging 30 tablets in 1 bottle
RxMed Kart's sole intention is to ensure that its consumers get expert-reviewed, accurate, and trustworthy information. However, the information contained herein should NOT use as a substitute for a qualified physician's advice. The information provided here is for informational purposes only. This may not cover all possible side effects, drug interactions, or warnings or alerts. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.